Literatur
Coselli JS et al (2016) Outcomes of 3309 thoracoabdominal aortic aneurysm repairs. J Thorac Cardiovasc Surg 151(5):1323–1337
Bone RC et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 136(5 Suppl):e28–2009
Hoover L et al (2006) Systemic inflammatory response syndrome and nosocomial infection in trauma. J Trauma 61(2):310–316 (discussion 316–7)
Hotchkiss RS, Monneret G, Payen D (2013) Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13(3):260–268
Bochicchio GV et al (2002) Persistent systemic inflammatory response syndrome is predictive of nosocomial infection in trauma. J Trauma 53(2):245–250 (discussion 250–1)
Jacobs MJ et al (2007) Surgical repair of thoracoabdominal aortic aneurysms. J Cardiovasc Surg (torino) 48(1):49–58
Vourc’h M, Roquilly A, Asehnoune K (2018) Trauma-induced damage-associated molecular patterns-mediated remote organ injury and Immunosuppression in the acutely ill patient. Front Immunol 9:1330
Manson J, Thiemermann C, Brohi K (2012) Trauma alarmins as activators of damage-induced inflammation. Br J Surg 99(Suppl 1):12–20
Ma KC et al (2018) The role of danger signals in the pathogenesis and perpetuation of critical illness. Am J Respir Crit Care Med 197(3):300–309
Zhang Q et al (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464(7285):104–107
Simmons JD et al (2013) Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects. Ann Surg 258(4):591–596 (discussion 596–8)
Kariko K et al (2004) mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279(13):12542–12550
He ZW et al (2013) HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-kappaB signaling pathways. Mediators Inflamm. https://doi.org/10.1155/2013/596716
Andrassy M et al (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117(25):3216–3226
Tsung A et al (2005) The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 201(7):1135–1143
Yang R et al (2006) Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med 12(4–6):105–114
Cohen MJ et al (2009) Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit Care 13(6):R174
Venereau E et al (2012) Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 209(9):1519–1528
Timmermans K et al (2016) Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med 42(4):551–561
Pockley AG, Shepherd J, Corton JM (1998) Detection of heat shock protein 70 (Hsp70) and anti-Hsp70 antibodies in the serum of normal individuals. Immunol Invest 27(6):367–377
Pittet JF et al (2002) Serum levels of Hsp 72 measured early after trauma correlate with survival. J Trauma 52(4):611–617 (discussion 617)
Foell D et al (2007) S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81(1):28–37
Roth J et al (1992) Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 186(3–4):304–314
Dar MI et al (2001) Single aortic cross-clamp technique reduces S‑100 release after coronary artery surgery. Ann Thorac Surg 71(3):794–796
Vos PE et al (2010) GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study. Baillieres Clin Neurol 75(20):1786–1793
Schober A, Bernhagen J, Weber C (2008) Chemokine-like functions of MIF in atherosclerosis. J Mol Med 86(7):761–770
Asare Y, Schmitt M, Bernhagen J (2013) The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis. Thromb Haemost 109(3):391–398
Payen D et al (2012) A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype. PLoS ONE 7(6):e35838
Stefaniak J et al (2015) Macrophage migration inhibitory factor as a potential predictor for requirement of renal replacement therapy after orthotopic liver transplantation. Liver Transpl 21(5):662–669
Al-Abed Y et al (2005) ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 280(44):36541–36544
Kleemann R et al (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408(6809):211–216
Gombert A et al (2017) Macrophage migration inhibitory factor predicts outcome in complex aortic surgery. Int J Mol Sci 18(11):2374
Li J et al (2018) Blocking macrophage migration inhibitory factor protects against cisplatin-induced acute kidney injury in mice. Mol Ther 26(10):2523–2532
Simon TP et al (2017) Plasma adrenomedullin in critically ill patients with sepsis after major surgery: a pilot study. J Crit Care 38:68–72
Tolppanen H et al (2017) Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock. Ann Intensive Care 7(1):6
Hinrichs S et al (2018) P283The precursor Pro-Adrenomedullin is an active protein: it supports cardiomyocyte survival and regulates cardiac inflammation related to myocardial infarction. Cardiovasc Res 114(suppl_1):S73–S73
Kawai C et al (2016) Circulating extracellular histones are clinically relevant mediators of multiple organ injury. Am J Pathol 186(4):829–843
Dear JW et al (2011) Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injury. J Immunol 187(6):3347–3352
Fiane AE et al (2003) Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair. Circulation 108(7):849–856
Welborn MB et al (2000) The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit Care Med 28(9):3191–3197
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Gombert, J. Grommes und M.J. Jacobs geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Gombert, A., Grommes, J. & Jacobs, M.J. Die klinische Relevanz von DAMP („damage-associated molecular pattern“) für den postoperativen Verlauf nach thorakoabdomineller Aortenchirurgie. Gefässchirurgie 24, 173–175 (2019). https://doi.org/10.1007/s00772-019-0510-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00772-019-0510-4